Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

0.00%

4.1¢ incannex healthcare limited

General discussion, page-18562

First 18562 Last

Share
Profile

Follow
Cripps2020

122 Posts.

115

18/11/23

08:53

Post #: 70974776
Share

Originally posted by tradingformils: ↑

My, oh, my...

Absolutely insane, insane buying opportunity this week!

I been picking more and more up and hope other have as well.

Hopefully this is the end of the selling, with Sud out, SMSF's out (sadly who couldn't hold on the Nasdaq), ETFs out, and so and so on. Hopefully the decks have been cleaned and upwards and onwards for the Nasdaq listing.

Let's focus on the fundamentals.

There’s 3 main things going on....

1- There’s the sleep apnoea OSA phase 2/3 FDA trial that’s about to start. I think this is expected to run for 12 months across 7 countries. Big trial and could really move the share price if we see a bull market next year, which I believe will happen (global liquidity is picking up and the tightening cycle is ending). The previous OSA phase 2 studies showed really promising results and we all know the drug works - we just need to test it on more people. On the back of this; they are doing BA-BE studies to text the pharmacokinetics and tolerability of the drug to ensure it meets the safety test in healthy volunteers. I wrote back in 2018 that we're coming for Resmed and we're so much closer now!

2- They are opening clarion clinics for psychedelic assisted therapy, aiming to treat approximately 600 people per year in normal working hours and substantially more in extended hour operations. If successful, this business could really scale domestically and internationally. We are also preparing to do a phase 2 FDA psilocybin assisted psychotherapy trial to treat GAD with psilocybin, which the clarion clinics (I believe) will come in handy for patient recruitment. This is obviously two parts and could end up becoming a multi billion dollar business in its own right. Currently waiting for ethics approval.

3- They are doing a phase 2 trial for rheumatoid arthritis which should take half a year. Currently waiting for ethics approval. This will be big as well.

Just look at the facts and what's happening with the business people.

The biotech sector has been terrible since early 2022, along with IHL's share price - just look at a chart of XBI (SPDR S&P Biotech ETF).

The Nasdaq listing could really open doors and end up becoming a blessing for those who can see further than their noses. If the Nasdaq hits all time highs early next year and the biotech sector (XBI) turns around, those who bought at these prices should be laughing.

I'm sleeping like a baby and hopefully other shareholders who can see the bigger picture are as well.
Hats off to Joel and the board for pulling this off.
It's been a terrible few weeks, but fortune favours the brave. Hopefully the decks are now clear and we can move upwards and onwards when we list on the Nasdaq in the coming weeks.
-Trading For Millions
DYOR

Expand

Great to see you posting on here again @tradingformils and still holding.

Hope you're well mate.

Good luck to all holders, the next 12 months post-US listing should be a wild ride and I'm very confident our patience will be thoroughly rewarded! 2024 is the year of IHL and the Blue Baggers.

IHL Price at posting: 4.1¢ Sentiment: Buy Disclosure: Held
18 Upvote

0 Great analysis

Reply

Top Stories

FG1

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

Talking Australia's very competitive property landscape: Realty Talks

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

IMR

Imricor raises $35M to pursue growth and expansion into Australia and NZ

AI stocks: What to expect in 2024-25

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

LKE

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

MCT

Metalicity looking for offers on Admiral Bay zinc project

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

GNX

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

There are more pages in this discussion • 1,432 more messages in this thread...

First 18562 Last

Add IHL (ASX) to my watchlist

General discussion, page-18562

Top Stories

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

Talking Australia's very competitive property landscape: Realty Talks

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

Imricor raises $35M to pursue growth and expansion into Australia and NZ

AI stocks: What to expect in 2024-25

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

Metalicity looking for offers on Admiral Bay zinc project

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

Featured News